The Influence of Vitamin D on Mineral Metabolism, Blood Pressure and Pulse Wave Analysis in Healthy Individuals

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized placebo controlled trial evaluating the effect of the recently recommended high doses of cholecalciferol (3000 IU/day) on mineral metabolism, blood pressure and pulse wave analysis in healthy individuals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vitamin D and Blood Pressure

NCT00459563

Hypertension

WITHDRAWN NA

Supplementation of Vitamin D in Patients With Type 2 Diabetes and Hypertension

NCT02204527

Hypertension

TERMINATED NA

The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors

NCT02750293

Vitamin D Deficiency

COMPLETED PHASE3

Vitamin D Supplementation and Muscle Characteristics in Trained Subjects

NCT02599675

Healthy Subjects, Trained

COMPLETED NA

Vitamin D, Blood Pressure, Lipids, Infection and Depression

NCT00960232

Hypovitaminosis D

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cholecalciferol

3000 IU cholecalciferol per day for 16 weeks

Group Type ACTIVE_COMPARATOR

cholecalciferol

Intervention Type DIETARY_SUPPLEMENT

Capsule cholecalciferol 1000 IU, 3 capsules per day for 16 weeks

placebo

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DIETARY_SUPPLEMENT

Empty capsules, 3 capsules per day for 16 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cholecalciferol

Capsule cholecalciferol 1000 IU, 3 capsules per day for 16 weeks

Intervention Type DIETARY_SUPPLEMENT

placebo

Empty capsules, 3 capsules per day for 16 weeks

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

D3-Vitamin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 18 years old
* p 25OH vitaminD\<50nmol/l
* signed informed consent

Exclusion Criteria

* receiving antihypertensive or antidiabetic treatment
* sarcoidoses
* history of kidney stones
* receiving 1-alfa-hydroxylated vitamin D treatment
* plasma creatinin \> 120 micromol/l
* ionised calcium \> 1,5 mmol/l
* treatment with calcimimetics
* active malignancy
* intestinal malabsorption
* active pancreatitis
* former hospitalisation due to alcoholic related disease
* using euphoriant drugs
* pregnancy or risk of being pregnant or lactating women
* Known allergy to cholecalciferol capsules

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes